Results 251 to 260 of about 1,571,541 (294)

Dual-Strategy Design of Molecular-Weight-Engineered PEDOT:PSS Complex Films for Enhanced Mechanical Ductility and Environmental Robustness. [PDF]

ACS Appl Mater Interfaces
Hu JD, Shih JL, Wu KY.
europepmc   +1 more source

Correction: The Safety and Efficacy of Low-Molecular-Weight Heparin in Pregnant Women With Rheumatic Heart Disease and Valves Replacement. [PDF]

Cureus
Alghamdi N, Alqahtani S, Allehyani L, Alosaimi H, Almutairi W, Alobaid S, Albackr HB, Aldakhil L, Alotaibi GS, Alqahtani FH.   +9 more
europepmc   +1 more source

An antibody targeting high-molecular-weight kininogen blocks contact system activation in a model of polymicrobial sepsis. [PDF]

J Thromb Haemost
Badimon A, Wu SJ, Calvano M, Strickland S, Norris EH.   +4 more
europepmc   +1 more source

Ultrahigh-resolution solid-state NMR for high-molecular weight proteins on GHz-class spectrometers. [PDF]

Sci Adv
Wang S, Ravula T, Stringer JA, Gor'kov PL, Warmuth OA, Williams CG, Thome AF, Mueller LJ, Rienstra CM.   +8 more
europepmc   +1 more source

RETRACTION: Evaluation of a Compounding Phospholipid Base for the Percutaneous Absorption of High Molecular Weight Drugs Using the Franz Finite Dose Model. [PDF]

Skin Res Technol
europepmc   +1 more source

Synthesis, Molecular Weight Characterization and Structure-Property Relationships of Ammonium Ionenes

, 2007
Erika M. Borgerding
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Low molecular weight heparins

Expert Opinion on Pharmacotherapy, 2000
Since its discovery, nearly 90 years, heparin has been used successfully for the treatment of thromboembolic processes. However, therapy with heparin has several important limitations. Most importantly, the poor predictability of its anticoagulant effects has led to the development of the low molecular weight heparins (LMWHs), which are derived from ...
O M, Aguilar, N S, Kleiman
openaire   +3 more sources